Association of adverse outcomes in a tuberculosis hospital with HIV infection
https://doi.org/10.34215/1609-1175-2025-2-73-77
Abstract
Objective: To investigate the effect of regional HIV and tuberculosis incidence on the number of adverse outcomes in a tuberculosis hospital. Material and methods. This study is retrospective and non-randomized. The analysis includes data from the Russian Federal Service for Surveillance in Healthcare (Roszdravnadzor) on the incidence, prevalence, and mortality of HIV infection and tuberculosis in the Primorsky Krai region, as well as medical records of deceased patients from the tuberculosis hospital during the period from 2014 to 2023. Results. The epidemiological situation of tuberculosis in Primorsky Krai remains unstable and tense, representing one of the leading causes of death among the HIV-positive population and significantly affecting the mortality rate of HIV-infected patients. Correlation analysis assessing the strength of the associations between regional incidence and mortality from HIV infection in the tuberculosis hospital showed no significant association (p > 0.05), which, in our opinion, indicates a lack of influence of the tuberculosis service on the processes of timely detection, early diagnosis, and treatment of HIV patients. There is a direct correlation between the increase in adverse outcomes from surgical complications and the rising number of HIV-infected patients in the tuberculosis hospital (p < 0.05); moreover, adverse outcomes among HIV patients accounted for up to 35% of all deaths. Conclusion. No observed trend toward a decrease in HIV-related mortality exists in Primorsky Krai. The majority of adverse outcomes in the tuberculosis hospital among patients with HIVassociated infections are due to insufficient geographical coverage for case detection and timely diagnosis, as well as low adherence of the patient population to tuberculosis chemoprophylaxis
About the Authors
S. A. Belov
Far Eastern Federal University; Seaside Regional Antituberculous Dispensary
Russian Federation
Russian Federation
Sergei A. Belov – Dr. Sci. (Med.), thoracic surgeon of the Medical Complex
10, build. No25 Ajax settlement, Russkiy Island, 690950, Vladivostok
M. G. Boby`reva
Seaside Regional Antituberculous Dispensary
Russian Federation
Russian Federation
A. A. Grigoryuk
Medical Center "Asklepiy"
Russian Federation
Russian Federation
Yu. I. Cyleva
Seaside Regional Antituberculous Dispensary
Russian Federation
Russian Federation
References
1. Tsybikova EB, Punga VV, Rusakova LI. Tuberculosis with concurrent HIV infection in Russia: statistics and correlations. Tuberculosis and Lung Diseases, 2018;96(12):9–17 (In Russ.) doi: 10.21292/2075-1230-2018-96-12-9-17
2. Bobyreva MG, Belov SA, Sudnischikov VV, Pimenov NA, Pyatanova AN. Analysis of feasibility of surgical treatment in fibrous cavernous pulmonary tuberculosis patients in Primorskiy region. Tuberculosis and Lung Diseases. 2019;97(5):67–68 (In Russ.) doi: 10.21292/2075-1230-2019-97-5-67-68
3. Punga VV, Rusakova LI, Jakimova MA, Izmajlova TV. Mortality of tuberculosis patients in some territories of the Russian Federation. Vestnik CNIIT. 2019;(2):64–66 (In Russ.) doi: 10.7868/S258766781906027X
4. Magis-Escurra C, Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBnet. Treatment outcomes of MDR-TB and HIV co-infection in Europe. European Respiratory Journal. 2017;49:1602363. doi: 10.1183/13993003.02363-2016
5. Frolova OP, Butylchenko OV, Stakhanov VA, Enilenis II, Romenko MA, Martel II. Causes of death in patients with tuberculosis and human immunodeficiency virus co-infection. National Health Care (Russia). 2021;2(1):59–62 (In Russ.) doi:10.47093/2713-069X.2021.2.1.59-62
6. Saenko SS, Sterlikov SA, Rusakova LI, Gaevaya LS, Nagibina LA, Frolov EG, Yukhnova YuYe, Novikova TV, Kononenko YuS, Podgainaya OA, Svicharskaya AK, Gudenkov MA, Surnacheva IF, Ovsyankina OV, Lehlyider MV. Predictors of lethal outcome of TB/ HIV patients. Current problems of health care and medical statistics. 2020;(1):314–334 (In Russ.) doi: 10.24411/2312-2935-2020-00022
7. Schukina IV, Usachev VN, Frolova OP, Ilyin VV, Sultanov LV, Karpova LN. Optimization of approaches to the prevention of tuberculosis in penitentiary institutions. Epidemiology and Vaccinal Prevention. 2016;88(3):45–49 (In Russ.) doi: 10.31631/2073-3046-2016-15-3-45-49
8. Senina AM, Medvinskiy ID. Specific features of tuberculosis relapses in HIV infected patients. Tuberculosis and Lung Diseases. 2018;96(10):41–47 (In Russ.) doi: 10.21292/2075-1230-2018-96-10-41-47
9. Mishin VJu, Mishina AV, Levchenko MV, Jergeshov AJe. Clinical manifestations and the course of newly diagnosed tuberculosis associated with HIV infection, based on a dynamic fouryear prospective cohort follow-up observation. Vestnik CNIIT. 2018;1(2):52–64 (In Russ.) doi: 10.7868/S2587667818010077
10. Sterlikov SA, Galkin VB, Rusakova LI, Maliev BM, Komkova MA, Ashenova GZh, Podgajnaya OA, Yuxnova EA, Milyutina PA, Ovsyankina OV. Treatment outcomes for patients with RR-TB/HIV, MDR-TB/ HIV and XDR-TB/HIV. In: TB/HIV in the Russian Federation. Epidemiology, clinical features and treatment outcomes: second edition. Moscow: RIO CNIIOIZ, 2019;57–59 (In Russ.)
11. Galkin VB, Ashenova GZh, Zyrjanova OG, Komkova MA, Kononenko DS, Maliev BM., Pirogova ND, Podgajnaya OA, Svicharskaya AK, Smerdin SV, Strelkov AN, Chiganova LN, Yuxnova EA. Hemotherapy outcomes in patients with tuberculosis associated with HIV infection. In: TB/HIV in the Russian Federation. Epidemiology, clinical features and treatment outcomes: second edition. Moscow: RIO «CNIIOIZ», 2018;47–56 (In Russ.)
Review
For citations:
Belov S.A., Boby`reva M.G., Grigoryuk A.A., Cyleva Yu.I. Association of adverse outcomes in a tuberculosis hospital with HIV infection. Pacific Medical Journal. 2025;(2):73-77. (In Russ.) https://doi.org/10.34215/1609-1175-2025-2-73-77
Views:
21
Email this article 